Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cafedrine/theodrenaline versus norepinephrine for intraoperative arterial hypotension after induction of general anesthesia
2021-001954-76Phase 3Completed
- Sponsor
- Ratiopharm
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hypotension comparing Cafedrine/theodrenaline with Norepinephrine (2 arms). Primary endpoint: Treatment related difference in average MAP during study phase 2. Started Nov 2021; status: completed.
02
Drugs
cafedrine + theodrenalinenorepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on 2021-001954-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001954-76.